Filing Details
- Accession Number:
- 0001144204-13-017925
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-27 17:46:19
- Reporting Period:
- 2013-03-25
- Filing Date:
- 2013-03-27
- Accepted Time:
- 2013-03-27 16:46:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235007 | Endocyte Inc | ECYT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1509422 | R Allen Ritter | 3000 Kent Ave Ste A1-100 West Lafayette IN 47906 | Vp Of Manufacturing/Cmc | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-03-25 | 1,000 | $11.00 | 14,705 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares were sold pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.
Billionaire Hedge Funds
